Author:
Sun Yingxian,Liu Xingli,Guo Liang,Pang Wenyue,Guo Xiaofan,Sun Zhaoqing,Li Zhanquan,Cui Xiaoying,Li Hui,Tao Guizhou,Wang Lanfeng,Zhou Changyong,Liu Ying,Shan Hongwei,Wang Manqing,Liu Mingxin,Li Jia,Yin Lei,Hu Dayi
Subject
Cardiology and Cardiovascular Medicine
Reference29 articles.
1. Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow-up according to infarct location;Henriques;Heart,2006
2. Pre-hospital thrombolysis in perspective;Danchin;Eur Heart J,2008
3. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo controlled clinical trial;AIMS trial study group;Lancet,1988
4. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes;Lee;J Biol Chem,1988
5. Pharmacokinetics and safety of a new bioengineered thrombolytic agent, human tissue urokinase type plasminogen activator in Chinese healthy volunteers;Liang;Eur J Drug Metab Pharmacokinet,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献